The first trial over cancer-related glyphosate exposure ended in a $289 million verdict for the plaintiff. Defendants Monsanto and its new parent company, Bayer AG, have already filed motions seeking to either have the award overturned or reduced or for the court to grant a new trial. In their motions, defense attorneys say that scientific evidence presented...
The post Monsanto Appeals Verdict in First Glyphosate Trial, But it’s Not Looking Good For the Defendant appeared first on Mass Torts Made Perfect.